AbCellera Biologics (ABCL) Shares Outstanding: 2020-2025
Historic Shares Outstanding for AbCellera Biologics (ABCL) over the last 6 years, with Sep 2025 value amounting to $299.0 million.
- AbCellera Biologics' Shares Outstanding rose 1.31% to $299.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $299.0 million, marking a year-over-year increase of 1.31%. This contributed to the annual value of $151.7 million for FY2019, which is N/A change from last year.
- According to the latest figures from Q3 2025, AbCellera Biologics' Shares Outstanding is $299.0 million, which was up 0.12% from $298.7 million recorded in Q2 2025.
- AbCellera Biologics' 5-year Shares Outstanding high stood at $299.0 million for Q3 2025, and its period low was $270.9 million during Q1 2021.
- Its 3-year average for Shares Outstanding is $294.1 million, with a median of $294.7 million in 2024.
- Data for AbCellera Biologics' Shares Outstanding shows a peak YoY spiked of 82.46% (in 2021) over the last 5 years.
- AbCellera Biologics' Shares Outstanding (Quarterly) stood at $281.2 million in 2021, then rose by 1.64% to $285.8 million in 2022, then increased by 1.41% to $289.8 million in 2023, then climbed by 1.86% to $295.2 million in 2024, then grew by 1.31% to $299.0 million in 2025.
- Its Shares Outstanding stands at $299.0 million for Q3 2025, versus $298.7 million for Q2 2025 and $298.4 million for Q1 2025.